IT1229502B - Composizioni contenenti bismuto idonee per uso terapeutico. - Google Patents

Composizioni contenenti bismuto idonee per uso terapeutico.

Info

Publication number
IT1229502B
IT1229502B IT8919172A IT1917289A IT1229502B IT 1229502 B IT1229502 B IT 1229502B IT 8919172 A IT8919172 A IT 8919172A IT 1917289 A IT1917289 A IT 1917289A IT 1229502 B IT1229502 B IT 1229502B
Authority
IT
Italy
Prior art keywords
bismuto
compositions containing
therapeutic use
aqueous solution
bismuth
Prior art date
Application number
IT8919172A
Other languages
English (en)
Other versions
IT8919172A0 (it
Inventor
Diego Furlan
Original Assignee
Euroresearch Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroresearch Srl filed Critical Euroresearch Srl
Publication of IT8919172A0 publication Critical patent/IT8919172A0/it
Priority to IT8919172A priority Critical patent/IT1229502B/it
Priority to ES90100737T priority patent/ES2052977T3/es
Priority to EP90100737A priority patent/EP0380950B1/en
Priority to DK90100737.7T priority patent/DK0380950T3/da
Priority to AT90100737T priority patent/ATE84214T1/de
Priority to DE9090100737T priority patent/DE69000713T2/de
Priority to CA002008068A priority patent/CA2008068A1/en
Priority to JP2007294A priority patent/JPH02262534A/ja
Priority to US07/466,764 priority patent/US4965382A/en
Application granted granted Critical
Publication of IT1229502B publication Critical patent/IT1229502B/it
Priority to GR920403132T priority patent/GR3006752T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
IT8919172A 1989-01-25 1989-01-25 Composizioni contenenti bismuto idonee per uso terapeutico. IT1229502B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT8919172A IT1229502B (it) 1989-01-25 1989-01-25 Composizioni contenenti bismuto idonee per uso terapeutico.
AT90100737T ATE84214T1 (de) 1989-01-25 1990-01-15 Wismuthaltiges arzneipraeparat.
EP90100737A EP0380950B1 (en) 1989-01-25 1990-01-15 Bismuth-containing composition
DK90100737.7T DK0380950T3 (da) 1989-01-25 1990-01-15 Fremgangsmåde til fremstilling af et bismuthbaseret præparat samt det aktive produkt i præparat
ES90100737T ES2052977T3 (es) 1989-01-25 1990-01-15 Composicion que contiene bismuto.
DE9090100737T DE69000713T2 (de) 1989-01-25 1990-01-15 Wismuthaltiges arzneipraeparat.
CA002008068A CA2008068A1 (en) 1989-01-25 1990-01-18 Bismuth-containing compositions suitable for therapeutic use
JP2007294A JPH02262534A (ja) 1989-01-25 1990-01-18 治療用に好適なビスマス含有組成物及びその作製方法
US07/466,764 US4965382A (en) 1989-01-25 1990-01-18 Bismuth-containing compositions suitable for therapeutic use
GR920403132T GR3006752T3 (it) 1989-01-25 1993-01-08

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919172A IT1229502B (it) 1989-01-25 1989-01-25 Composizioni contenenti bismuto idonee per uso terapeutico.

Publications (2)

Publication Number Publication Date
IT8919172A0 IT8919172A0 (it) 1989-01-25
IT1229502B true IT1229502B (it) 1991-09-03

Family

ID=11155495

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8919172A IT1229502B (it) 1989-01-25 1989-01-25 Composizioni contenenti bismuto idonee per uso terapeutico.

Country Status (10)

Country Link
US (1) US4965382A (it)
EP (1) EP0380950B1 (it)
JP (1) JPH02262534A (it)
AT (1) ATE84214T1 (it)
CA (1) CA2008068A1 (it)
DE (1) DE69000713T2 (it)
DK (1) DK0380950T3 (it)
ES (1) ES2052977T3 (it)
GR (1) GR3006752T3 (it)
IT (1) IT1229502B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
CN1055865C (zh) * 1995-10-30 2000-08-30 吴祁荃 X线结肠专用双对比造影剂
US6699912B2 (en) * 2000-04-12 2004-03-02 Gastropal Partners Method for preparing colloidal solution of bismuth sodium tartrate
US6482865B1 (en) 2000-04-12 2002-11-19 Gastropal Partners Method for preparing colloidal solution of bismuth sodium tartrate
RU2496719C1 (ru) * 2012-02-17 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут калий цитрата
RU2570610C1 (ru) * 2014-10-02 2015-12-10 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут аммоний цитрата
CN106632172A (zh) * 2016-12-28 2017-05-10 李玉成 枸橼酸抗坏血酸铋钾及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1536711A (en) * 1924-10-17 1925-05-05 Farbenfab Vorm Bayer F & Co Complex sodium bismuth salt of triglycollamic acid
US1663201A (en) * 1926-05-28 1928-03-20 Searle & Co Process for making bismuth tartrates and product produced thereby
US2054731A (en) * 1934-01-02 1936-09-15 Boots Pure Drug Co Ltd Organic salts of bismuth and process for producing same
US2232411A (en) * 1937-05-15 1941-02-18 George A Breon & Company Inc Bismuth hydroxylates of polyhydroxydicarboxylic acid salts
US2348984A (en) * 1942-06-25 1944-05-16 Robert A Lehman Sodium bismuth triglycollamate
US3840575A (en) * 1972-08-03 1974-10-08 Shirley Atkins Macclaren Bismuth subcompounds and their methods of preparation
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
ES2040307T3 (es) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh Procedimiento para producir un preparado medicamentoso liquido que contiene bismuto.

Also Published As

Publication number Publication date
EP0380950A2 (en) 1990-08-08
DE69000713D1 (de) 1993-02-18
CA2008068A1 (en) 1990-07-25
DK0380950T3 (da) 1993-02-08
EP0380950A3 (en) 1990-12-27
JPH02262534A (ja) 1990-10-25
ES2052977T3 (es) 1994-07-16
IT8919172A0 (it) 1989-01-25
EP0380950B1 (en) 1993-01-07
GR3006752T3 (it) 1993-06-30
ATE84214T1 (de) 1993-01-15
US4965382A (en) 1990-10-23
DE69000713T2 (de) 1993-05-06

Similar Documents

Publication Publication Date Title
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
CS782686A2 (en) Method of benzimidazole derivatives production
EP1181929A3 (en) Method of potentiating an immune response and compositions therefor
NZ230005A (en) Solid, porous unitary form prepared by lyophilising a paste comprising micro- and/or nano-particles
PT85829A (en) Therapeutic agents
IL89840A0 (en) Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
IT1229502B (it) Composizioni contenenti bismuto idonee per uso terapeutico.
GB1478742A (en) Pharmaceutical compositions and their preparation
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
IT7829910A0 (it) Derivati dell'acido fosfonoso, procedimenti per la loro preparazione e loro impiego per combattere microorganismi.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
ATE65395T1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
IL72234A (en) Water-soluble 8-acylated rifampicin derivatives,their preparation and liquid pharmaceutical compositions containing them
JPS5543041A (en) Immunity raising agent
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
JPS5296745A (en) Aqueous agent for immunity control
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
JPS5369875A (en) Preparation of luminous body contg. luminous bacteria
GB1025920A (en) Method of producing chlorpromazine salt
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives